211 related articles for article (PubMed ID: 23893323)
1. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
[TBL] [Abstract][Full Text] [Related]
2. Bilateral congenital corneal anesthesia in a patient with SCN9A mutation, confirmed primary erythromelalgia, and paroxysmal extreme pain disorder.
Kim DT; Rossignol E; Najem K; Ospina LH
J AAPOS; 2015 Oct; 19(5):478-9. PubMed ID: 26486037
[TBL] [Abstract][Full Text] [Related]
3. Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7).
Deuis JR; Kumble S; Keramidas A; Ragnarsson L; Simons C; Pais L; White SM; Vetter I
Hum Mol Genet; 2024 Jan; 33(2):103-109. PubMed ID: 37721535
[TBL] [Abstract][Full Text] [Related]
4. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
[TBL] [Abstract][Full Text] [Related]
5. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P
Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232
[TBL] [Abstract][Full Text] [Related]
6. Mutation in Na
Haehner A; Hummel T; Heinritz W; Krueger S; Meinhardt M; Whitcroft KL; Sabatowski R; Gossrau G
Eur J Pain; 2018 Nov; 22(10):1767-1773. PubMed ID: 29934995
[TBL] [Abstract][Full Text] [Related]
7. Paediatric hypertension-associated erythromelalgia responds to corticosteroids and is not associated with SCN9A mutations.
Morales PS; Escobar RG; Lizama M; Aglony M; Salomon J; Drenth JP; Borzutzky A
Rheumatology (Oxford); 2012 Dec; 51(12):2295-6. PubMed ID: 22718865
[No Abstract] [Full Text] [Related]
8. Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia.
Klein CJ; Wu Y; Kilfoyle DH; Sandroni P; Davis MD; Gavrilova RH; Low PA; Dyck PJ
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):386-91. PubMed ID: 23129781
[TBL] [Abstract][Full Text] [Related]
9. A new Nav1.7 mutation in an erythromelalgia patient.
Estacion M; Yang Y; Dib-Hajj SD; Tyrrell L; Lin Z; Yang Y; Waxman SG
Biochem Biophys Res Commun; 2013 Mar; 432(1):99-104. PubMed ID: 23376079
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series.
Arthur L; Keen K; Verriotis M; Peters J; Kelly A; Howard RF; Dib-Hajj SD; Waxman SG; Walker SM
J Pediatr; 2019 Mar; 206():217-224.e9. PubMed ID: 30416015
[TBL] [Abstract][Full Text] [Related]
11. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X
Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532
[TBL] [Abstract][Full Text] [Related]
12. A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers.
Wu MT; Huang PY; Yen CT; Chen CC; Lee MJ
PLoS One; 2013; 8(1):e55212. PubMed ID: 23383113
[TBL] [Abstract][Full Text] [Related]
13. Primary erythromelalgia: a review.
Tang Z; Chen Z; Tang B; Jiang H
Orphanet J Rare Dis; 2015 Sep; 10():127. PubMed ID: 26419464
[TBL] [Abstract][Full Text] [Related]
14. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile.
McDonnell A; Schulman B; Ali Z; Dib-Hajj SD; Brock F; Cobain S; Mainka T; Vollert J; Tarabar S; Waxman SG
Brain; 2016 Apr; 139(Pt 4):1052-65. PubMed ID: 26920677
[TBL] [Abstract][Full Text] [Related]
15. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
[TBL] [Abstract][Full Text] [Related]
16. Autonomic dysfunction in SCN9A-associated primary erythromelalgia.
Kim MK; Yuk JW; Kim HS; Park KJ; Kim DS
Clin Auton Res; 2013 Apr; 23(2):105-7. PubMed ID: 23152140
[TBL] [Abstract][Full Text] [Related]
17. A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation.
Watabe D; Tominaga M; Toyama S; Takamori K; Nakano H; Amano H
J Dermatol; 2023 Jul; 50(7):938-941. PubMed ID: 36815391
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.
Cregg R; Laguda B; Werdehausen R; Cox JJ; Linley JE; Ramirez JD; Bodi I; Markiewicz M; Howell KJ; Chen YC; Agnew K; Houlden H; Lunn MP; Bennett DL; Wood JN; Kinali M
Neuromolecular Med; 2013 Jun; 15(2):265-78. PubMed ID: 23292638
[TBL] [Abstract][Full Text] [Related]
19. Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders.
Yuan JH; Cheng X; Matsuura E; Higuchi Y; Ando M; Hashiguchi A; Yoshimura A; Nakachi R; Mine J; Taketani T; Maeda K; Kawakami S; Kira R; Tanaka S; Kanai K; Dib-Hajj F; Dib-Hajj SD; Waxman SG; Takashima H
J Peripher Nerv Syst; 2023 Dec; 28(4):597-607. PubMed ID: 37555797
[TBL] [Abstract][Full Text] [Related]
20. Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.
Choi JS; Zhang L; Dib-Hajj SD; Han C; Tyrrell L; Lin Z; Wang X; Yang Y; Waxman SG
Exp Neurol; 2009 Apr; 216(2):383-9. PubMed ID: 19162012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
